Geraldine Bueken Ramzi

Directrice Xr4heritage, Experte en stratégie de contenus et innovation culturelle #mediaIA #Avatars

Brussels Metropolitan Area

About

I’m a producer and screenwriter, specializing in content strategy and phygital experiences (physical + digital). Through the XR4HERITAGE program, I imagine and lead impact-driven immersive projects across Europe, Africa, and Quebec, at the intersection of arts, archives, emerging narratives, and XR + AI technologies. I also design and produce generative AI films, exploring new formats for creation and cultural transmission. I am the founder of AVATARS, the first catalog of AI conversational avatars entirely dedicated to highlighting historical figures and creating new forms of dialogue with the past. In 2026, I will launch NEXUS, the reference platform for the future of social memory experiences: a tool designed for solution providers and project leaders using digital technologies to transform how audiences experience, share, and reinvent memory. I support institutions, networks, and international partners in their immersive experience projects — UNITED XR EU is one of my clients, for whom I work as a curator. Through my label XR4Heritage, which I founded and lead, I also run Invisible Festival, our annual event dedicated to the future of memory experiences and immersive heritage. 📩 Looking to create a phygital experience, an XR/AI project, or a high-impact collective story? Let’s connect. #changemaker #XRHeritage #collectivestories #immersion #interactivity #narrative #GenerativeAI #ConversationalAI #Phygital

Experience

  • Culture & Heritage Curator at UnitedXR Europe

  • Curatrice TRACK CULTURE & PATRIMOINE at Stereopsia

  • Responsable Pays : BELGIQUE at Agence francophone de l'Intelligence Artificielle (AFRIA)

  • Founder-Manager at XR4Heritage

  • Co-créatrice/co-scénariste de la bible de série TV DOUBLE L at 3PLUMES

    Bible de série TV co-créée avec Nadia Kamali - en développement avec la réalisatrice productrice Euzhan Palcy. Casting : Layla Mettsitane.